Prophylaxis of meningococcal meningitis;Prophylaxe der meningokokkenmeningitis

Nervenarzt

Volumn 71, Issue 2, 2000, Pages 134-137

  Kastenbauer, S ^a   Grabein, B ^b   Pfister, H W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

Meningococcal meningitis; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; MENINGOCOCCUS VACCINE; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; CHEMOPROPHYLAXIS; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIC MENINGITIS; GERMANY; HUMAN; INCIDENCE; MENINGOCOCCOSIS; MORTALITY; PROPHYLAXIS; RESPIRATORY SYSTEM;

ANTI-BACTERIAL AGENTS; CONTACT TRACING; DISEASE NOTIFICATION; GERMANY; HUMANS; MENINGITIS, MENINGOCOCCAL;

EID: 0034067527     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050020     Document Type: Article

References (22)

1. Abramson JS, Spika JS (1985) Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. J Infect Dis 151:370-371
2. Al'Aldeen AA, Cartwright KA (1996) Neisseria meningitidis: vaccines and vaccine candidates. J Infect 33:153-157
3. Bhisitkul DM, Hogan AE, Tanz RR (1994) The role of bacterial antigen detection tests in the diagnosis of bacterial meningitis. Pediatr Emerg Care 10:67-71
4. Broome CV (1986) The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18 [Suppl A]:25-34
5. Cartwright K, Ala'Aldeen KAV (1997) Neisseria meningitidis: clinical aspects. J Infection 34:15-19
6. Cartwright K, Reilly S, White D, Stuart J (1992) Early treatment with parenteral penicillin in meningococcal disease. Br Med J 305:143-147
7. Ellison RT, Kohler PF, Curd JG, Judson FN, Reller LB (1983) Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med 308:913-916
8. Francke EL, Neu HC (1981) Postsplenectomy infection. Surg Clin North Am 61:135-155
9. Gaunt PN, Lambert BE (1988) Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother 21:489-496
10. Goldschneider I, Gotschlich EC, Artenstein MS (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129:1307-1326
11. Jones DM, Mallard RH (1993) Age incidence of meningococcal infection England and Wales, 1984-1991. J Infect 27:83-88
12. Jones DM, Sutcliffe EM (1990) Meningococci with reduced susceptibility to penicillin. Lancet 335:863-864
13. Kristiansen BE, Knapskog AB (1996) Secondary prevention of meningococcal disease. Br Med J 312:591-592
14. Moore PS (1992) Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis 14:515-525
15. Oppenheim BA (1997) Antibiotic resistance in Neisseria meningitidis. Clin Infect Dis 24 [Suppl 1]:98-101
16. Quagliarello VJ, Scheld WM (1997) Treatment of bacterial meningitis. N Engl J Med 336:708-716
17. Robert Koch Institut (1993) Meningokokkenerkrankungen in Deutschland 1997. Epidemiol Bull 10/98:63-64
18. Robert Koch Institut (1999) Meningokokken als Krankheitserreger in Deutschland 1998. Epidemiol Bull 9/99:56-57
19. Robert Koch Institut (1993) Ratgeber Infektionskrankheiten. 2. Folge: Meningokokken-Erkrankungen. Epidemiol Bull 11/99:68-71
20. Schwartz B, Al-Tobaiqi A, Al-Ruwais A et al. (1988) Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet 1:1239-1242
21. Strang JR, Pugh EJ (1992) Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. Br Med J 305:141-143
22. Sutcliffe EM, Jones DM, el-Sheikh S, Percival A (1988) Penicillin-insensitive meningococci in the UK. Lancet 1:657-658